BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 303 filers reported holding BLUEBIRD BIO INC in Q4 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $97,460 | +56.2% | 29,623 | +51.0% | 0.00% | – |
Q1 2023 | $62,401 | -54.0% | 19,623 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $135,791 | +102.7% | 19,623 | +85.1% | 0.00% | 0.0% |
Q3 2022 | $67,000 | +48.9% | 10,600 | -1.9% | 0.00% | – |
Q2 2022 | $45,000 | -27.4% | 10,800 | -14.9% | 0.00% | -100.0% |
Q1 2022 | $62,000 | -42.6% | 12,686 | +16.9% | 0.00% | -50.0% |
Q4 2021 | $108,000 | -58.1% | 10,849 | +34.6% | 0.00% | -66.7% |
Q2 2021 | $258,000 | +6.2% | 8,060 | +0.1% | 0.01% | 0.0% |
Q1 2021 | $243,000 | -17.3% | 8,050 | +18.6% | 0.01% | -33.3% |
Q4 2020 | $294,000 | -6.4% | 6,786 | +16.5% | 0.01% | -30.8% |
Q3 2020 | $314,000 | -8.7% | 5,825 | +3.3% | 0.01% | -31.6% |
Q2 2020 | $344,000 | +32.8% | 5,639 | +0.2% | 0.02% | +18.8% |
Q1 2020 | $259,000 | -48.8% | 5,630 | -2.4% | 0.02% | -38.5% |
Q4 2019 | $506,000 | -0.4% | 5,770 | +4.2% | 0.03% | -13.3% |
Q3 2019 | $508,000 | -27.4% | 5,538 | +0.7% | 0.03% | -31.8% |
Q2 2019 | $700,000 | -20.7% | 5,500 | -2.0% | 0.04% | -25.4% |
Q1 2019 | $883,000 | +58.8% | 5,613 | +0.2% | 0.06% | +59.5% |
Q4 2018 | $556,000 | +51.5% | 5,601 | +123.1% | 0.04% | +48.0% |
Q3 2018 | $367,000 | +54.9% | 2,511 | +66.2% | 0.02% | +38.9% |
Q2 2018 | $237,000 | -8.8% | 1,511 | -0.6% | 0.02% | -10.0% |
Q1 2018 | $260,000 | -34.5% | 1,520 | -31.7% | 0.02% | -25.9% |
Q4 2017 | $397,000 | +67.5% | 2,227 | +29.0% | 0.03% | +58.8% |
Q3 2017 | $237,000 | – | 1,727 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |